Literature DB >> 2224844

Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy.

Y S Cho-Chung1.   

Abstract

Two isoforms of the regulatory subunits of cyclic AMP (cAMP)-dependent protein kinase that bind cAMP are inversely expressed during ontogeny and cell differentiation. These cAMP-binding receptor proteins in harmony may regulate the growth of normal cells and their differentiation into nondividing states. Cancer cells can also be made to differentiate and stop growing when the functional balance of these cAMP receptor proteins is restored by treatment with site-selective cAMP analogues or by the use of an antisense oligodeoxynucleotide, suggesting new approaches to cancer treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2224844

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

Review 1.  Modified cell proliferation due to electrical currents.

Authors:  L Vodovnik; D Miklavcic; G Sersa
Journal:  Med Biol Eng Comput       Date:  1992-07       Impact factor: 2.602

2.  Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression.

Authors:  Y S Cho; Y G Park; Y N Lee; M K Kim; S Bates; L Tan; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves".

Authors:  Michael Getz; Padmini Rangamani; Pradipta Ghosh
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-04-23

4.  The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitro.

Authors:  Dragana Janković; Milica Pesić; Jasna Marković; Selma Kanazir; Ivanka Marković; Ljubisav Rakić; Sabera Ruzdijić
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

5.  Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase.

Authors:  R K Srivastava; A R Srivastava; S J Korsmeyer; M Nesterova; Y S Cho-Chung; D L Longo
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

6.  Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.

Authors:  I Bongarzone; N Monzini; M G Borrello; C Carcano; G Ferraresi; E Arighi; P Mondellini; G Della Porta; M A Pierotti
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

7.  Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts.

Authors:  A Budillon; A Cereseto; A Kondrashin; M Nesterova; G Merlo; T Clair; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  8-Chloroadenosine 3',5'-monophosphate induces cell cycle arrest and apoptosis in multiple myeloma cells through multiple mechanisms.

Authors:  Yi-Min Cheng; Qi Zhu; Yi-Yun Yao; Yong Tang; Ming-Ming Wang; Li-Fang Zou
Journal:  Oncol Lett       Date:  2012-09-11       Impact factor: 2.967

9.  Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.

Authors:  Li-Yan Khor; Kyounghwa Bae; Tahseen Al-Saleem; Elizabeth H Hammond; David J Grignon; William T Sause; Miljenko V Pilepich; Paul P Okunieff; Howard M Sandler; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

10.  Selective inhibition of adenylate cyclase in bovine cortex by quinones: a novel cellular substrate for quinone cytotoxicity.

Authors:  O Moullet; J L Dreyer
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.